Healthcare -
Drug Manufacturers - General - NYSE - CH
$ 110.62
1.44 %
$ 218 B
Market Cap
18.84
P/E
NVS - COST OF REVENUE
Cost of Revenue NVS - Novartis AG
12.8 B
LAST VALUE
-8.99%
2 YEAR CAGR
-2.32%
5 YEAR CAGR
-2.97%
10 YEAR CAGR